Skip to content
Learning to Love Big Pharma episode artwork

Jun 29, 2020 13 min

Learning to Love Big Pharma

from Prognosis: Misconception Hosted by Bloomberg

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Learning to Love Big Pharma

0:00 13:27

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Prognosis: Misconception?

This episode is 13 minutes long.

When was this Prognosis: Misconception episode published?

This episode was published on June 29, 2020.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Prognosis: Misconception episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.